By Dr Pranab Gyawali, Consultant Gastroenterologist In my 25 years as a gastroenterologist treating patients with Crohns disease, ulcerative colitis (UC), and complex gut symptoms, it is only recently that I have seen such a massive surge of interest in BPC 157
From a purely pharmacological standpoint, you can stop at any dose, at any time, without dangerous physical consequences
Decisions about starting, stopping, or switching medications should be individualized and made in partnership with your prescribing clinician, incorporating your eye health and the small but real NAION signal
Current research suggests retatrutide can cause several side effects
The tripeptide has high affinity for copper(II) ions, chelating them and facilitating cellular uptake without the oxidative risk of free copper
GLP-1 & GIP Pathways May Reduce Binge Drinking and Alcohol-Related Harm Very pleased to share that our new Molecular Psychiatry study suggests that the same biological pathways targeted by medications like semaglutide and tirzepatide may also reduce binge drinking and alcohol-related harm